Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (4): 49-54.doi: 10.6040/j.issn.1673-3770.0.2021.278
JIANG Chao, ZHOU Xuanchen, HAN Jie, YUE Zhiyong
CLC Number:
[1] Li Y, Ou X, Hu C. Prevalence and prognostic impact of synchronous distant metastases in patients with hypopharynx squamous cell carcinomas: a SEER-based study[J]. J Cancer, 2019, 10(3): 620-626. doi:10.7150/jca.28554. [2] Eckel HE, Bradley PJ. Natural history of treated and untreated hypopharyngeal cancer[J]. Adv Otorhinolaryngol, 2019, 83: 27-34. doi:10.1159/000492305. [3] Pai SI, Faivre S, Licitra L, et al. Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients(CheckMate 141 and KEYNOTE 040)[J]. J Immunother Cancer, 2019, 7(1): 96. doi:10.1186/s40425-019-0578-0. [4] McGranahan N, Swanton C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution[J]. Cancer Cell, 2015, 27(1): 15-26. doi:10.1016/j.ccell.2014.12.001. [5] McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: past, present, and the future[J]. Cell, 2017, 168(4): 613-628. doi:10.1016/j.cell.2017.01.018. [6] Wiegand S, Zimmermann A, Wilhelm T, et al. Survival after distant metastasis in head and neck cancer[J]. Anticancer Res, 2015, 35(10): 5499-5502. [7] Liu JC, Bhayani M, Kuchta K, et al. Patterns of distant metastasis in head and neck cancer at presentation: Implications for initial evaluation[J]. Oral Oncol, 2019, 88: 131-136. doi:10.1016/j.oraloncology.2018.11.023. [8] Spector JG, Sessions DG, Haughey BH, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx[J]. Laryngoscope, 2001, 111(6): 1079-1087. doi:10.1097/00005537-200106000-00028. [9] Suzuki A, Kashiwagi N, Doi H, et al. Patterns of bone metastases from head and neck squamous cell carcinoma[J]. Auris Nasus Larynx, 2020, 47(2): 262-267. doi:10.1016/j.anl.2019.08.001. [10] Bollig CA, Newberry CI, Galloway TLI, et al. Prognostic impact of metastatic site and pattern in patients with metastatic head and neck cancer[J]. Laryngoscope, 2021, 131(6): E1838-E1846. doi:10.1002/lary.29208. [11] Perrakis A, Juratli TA, Hohenberger W, et al. Surgery for metastases, anatomical and ethical limits. Special aspect: oligometastases[J]. Der Chir Zeitschrift Fur Alle Gebiete Der Oper Medizen, 2016, 87(3): 208-215. doi:10.1007/s00104-015-0147-0. [12] 崔晓波. 诱导化疗在局部晚期下咽癌治疗中的意义[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 10-17.doi: 10.1016/j.anl.2019.08.001. CUI Xiaobo. Significance of induction chemotherapy in late treatment of locally advanced hypo-pharyngeal cancer[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 10-17.doi: 10.1016/j.anl.2019.08.001. [13] Kuo P, Sosa JA, Burtness BA, et al. Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base[J]. Cancer, 2016, 122(12): 1853-1860. doi:10.1002/cncr.29962. [14] Vincent AG, Wang W, Shokri T, et al. Treatment of oligometastatic disease in squamous cell carcinoma of the head and neck[J]. Laryngoscope, 2021, 131(5): E1476-E1480. doi:10.1002/lary.29115. [15] Oweira H, Petrausch U, Helbling D, et al. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: a Surveillance Epidemiology and End Results database analysis[J]. World J Gastroenterol, 2017, 23(10): 1872-1880. doi:10.3748/wjg.v23.i10.1872. [16] Keutgen XM, Nilubol N, Glanville J, et al. Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors[J]. Surgery, 2016, 159(1): 311-318. doi:10.1016/j.surg.2015.05.042. [17] Hüttner FJ, Schneider L, Tarantino I, et al. Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis[J]. Langenbecks Arch Surg, 2015, 400(6): 715-723. doi:10.1007/s00423-015-1323-x. [18] Ruan RW, Chen SS, Tao YL, et al. Retrospective analysis of predictive factors for lymph node metastasis in superficial esophageal squamous cell carcinoma[J]. Sci Rep, 2021, 11: 16544. doi:10.1038/s41598-021-96088-y. [19] Chen XB, Guo TT. Development of a nomogram for predicting survival of patients with ovarian serous cystadenocarcinoma after surgery based on SEER database[J]. J Zhejiang Univ(Med Sci), 2021, 50(3): 369-374. doi:10.3724/zdxbyxb-2021-0188. |
[1] | LI Jingjing, WU Xinxin, MAO Ning, ZHENG Guibin, MU Yakui, CHU Tongpeng, JIA Chuanliang, ZHENG Haitao, MI Jia, SONG Xicheng. CT-based radiomics nomogram for the preoperative prediction of central lymph node metastases of papillary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 51-59. |
[2] | WANG YayueOverview,SUN JuanGuidance. Research progress on differentially-expressed protein kinases and inhibitors in hypopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 119-124. |
[3] | This study aims to evaluate the level of expression of cyclin E2 in hypopharyngeal cancer and its relationship with clinical characteristics as well as prognosis. MethodsThe protein levels of cyclin E2 in tumor tissues and adjacent normal tissues were assessed by immunohistochemistry staining in 50 cases of hypopharyngeal cancer. The relationship between the expression level of cyclin E2 and clinical data was analyzed using the SPSS software. ResultsProtein levels of cyclin E2 in hypopharyngeal cancer were higher than protein levels of cyclin E2 in normal tissue(Z=-5.764,P=0.000). The cyclin E2 level in tumor tissue correlated with the tumor staging(Z=-1.995, P=0.046)and lymph node metastasis(Z=-2.176, P=0.030). The 5-year survival rates of patients with cyclin E2 positive and negative expression were 40.2% and 81.8%, respectively. Patients with high expression levels of cyclin E2 had a lower survival rate(χ=6.317, P=0.012). ConclusionThe abnormal expression of cyclin E2 protein in tumor tissues indicates that cyclin E2 may be involved in the development of hypopharyngeal cancer and could be a potential diagnostic and prognostic molecular marker.. Expression of cyclin E2 in hypopharyngeal cancer and its clinical significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(5): 132-137. |
[4] | YUE Jianlin, LIN Yun, JIANG Zhen, LI Xuexin, SUN Ruijie, PAN Xinliang, LIU Dayu. Application of the hemi-tongue root flap for the repair of lateral defects in the pharyngeal cavity [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(1): 63-66. |
[5] | HUANG He, OUYANG Hui. Risk factors and prognosis of esophageal cancer with hypopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 82-86. |
[6] | JIANG Chang, XU Chengbi, XIN Ding, JU Yang, LI Hongyan, WANG Jinyue.. Axillary lymph node metastasis in patient with hypopharyngeal carcinoma: report of 1 case and literature review. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(1): 90-92. |
[7] | QIAN Ye, LEI Da-peng, JIN Tong, LIU Da-yu, XU Feng-lei, PAN Xin-liang. Expression of Slit2 and its correlation with lymphatic vessel density in hypopharyngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(5): 12-15. |
[8] | YE Ping, SUN Rui-jie, JIN Tong, QIAN Ye, WEI Dong-min, PAN Xin-liang. Expression and significance of Caveolin-1 in hypopharyngeal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(5): 22-24. |
[9] | LIN Bin,WANG Hui-ge . Hypopharynx-esophageal carcinoma misdiagnosed as thyroid disease: a clinic analysis of 4 cases [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(3): 22-24. |
[10] | CAO Han-hai1, DING Hai-xia2, PENG Hong-juan3. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(3): 25-27. |
[11] | L Mei1, DONG Pin2, SHE Cui-ping3, DU Cui-ping1, LI Yong1, XU Er-dong1. Differentially expressed genes in 3 cases of hypopharyngeal carcinoma and normal tissues by cDNA microarray [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(5): 5-. |
[12] |
GAO Xingqiang1, ZHAO Dean1, FANG Zheng2, YU Xiuyi2 . hypopharynx and thoracic segmentesophagus synchronous multiple primary carcinoma: a clinical analysis of 5 cases [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2009, 23(2): 24-26 . |
|